Terauchi M, Yanagawa T, Ishikawa N, Ito K, Fukazawa T, Maruyama H, Saruta T
Department of Medicine, Keio University, Tokyo, Japan.
J Endocrinol Invest. 2003 Dec;26(12):1208-12. doi: 10.1007/BF03349159.
Hashimoto's thyroiditis (HT) is an autoimmune disease of the thyroid gland, and like many other autoimmune diseases, it is associated with the HLA and CTLA-4 gene. We have examined the distribution of the HLA DRB40101 allele and a CTLA-4 exon 1 A/G polymorphism in Japanese HT patients and controls and investigated possible interactions of these genes with thyroid function. Seventy Japanese HT patients and 105 controls were included in this study. HT was diagnosed on the basis of positivity for thyroid peroxidase (TPO) autoantibodies and the presence of a palpable diffuse goiter. Genotyping was performed by polymerase chain reaction (PCR)-based methods. CTLA-4-GG or -AG was more prevalent in the patients, and the odds ratio for the G allele was 4.95. The frequency of DRB40101-positive individuals was significantly higher in HT (odds ratio=2.17). The TSH values of HT patients at the time of diagnosis were compared to CTLA-4 genotype and HLA-DRB40101 positivity. They were slightly higher in the CTLA-4-AG group than in the -GG group and significantly higher in the HLA-DRB40101-positive group than in the -negative group (p<0.01). When the TSH values were compared in 4 groups based on positivity or negativity for HLA-DRB40101 and CTLA-4 GG or AG, they were found to be significantly higher in the CTLA-4-AG and HLA-DRB40101-positive group than in the 3 other groups (F=5.75, 3 degrees of freedom, p<0.01). These findings suggest that the interaction between the HLA-DRB4 and CTLA-4 genes determines the thyroid function of TPO-positive goitrous Japanese HT patients.
桥本甲状腺炎(HT)是一种甲状腺自身免疫性疾病,与许多其他自身免疫性疾病一样,它与人类白细胞抗原(HLA)和细胞毒性T淋巴细胞相关抗原4(CTLA-4)基因有关。我们检测了日本HT患者和对照组中HLA DRB40101等位基因的分布以及CTLA-4外显子1 A/G多态性,并研究了这些基因与甲状腺功能之间可能的相互作用。本研究纳入了70例日本HT患者和105例对照。HT根据甲状腺过氧化物酶(TPO)自身抗体阳性和可触及的弥漫性甲状腺肿诊断。基因分型采用基于聚合酶链反应(PCR)的方法。CTLA-4 -GG或-AG在患者中更为普遍,G等位基因的优势比为4.95。HT患者中DRB40101阳性个体的频率显著更高(优势比=2.17)。将HT患者诊断时的促甲状腺激素(TSH)值与CTLA-4基因型和HLA-DRB40101阳性情况进行比较。CTLA-4 -AG组的TSH值略高于-GG组,HLA-DRB40101阳性组的TSH值显著高于阴性组(p<0.01)。当根据HLA-DRB40101和CTLA-4 GG或AG的阳性或阴性将TSH值在4组中进行比较时,发现CTLA-4 -AG和HLA-DRB40101阳性组的TSH值显著高于其他3组(F=5.75,自由度为3,p<0.01)。这些发现表明,HLA-DRB4和CTLA-4基因之间的相互作用决定了TPO阳性甲状腺肿日本HT患者的甲状腺功能。